148 related articles for article (PubMed ID: 12037451)
1. Euclidean and fractal computer-assisted corneofungimetry: a comparison of 2% ketoconazole and 1% terbinafine topical formulations.
Arrese JE; Fogouang L; Piérard-Franchimont C; Piérard GE
Dermatology; 2002; 204(3):222-7. PubMed ID: 12037451
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.
Piérard GE; Arrese JE; De Doncker P
J Am Acad Dermatol; 1995 Mar; 32(3):429-35. PubMed ID: 7868711
[TBL] [Abstract][Full Text] [Related]
3. Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences.
Piérard-Franchimont C; Vroome V; Cauwenbergh G; Piérard GE
Skin Pharmacol Physiol; 2005; 18(2):98-102. PubMed ID: 15767771
[TBL] [Abstract][Full Text] [Related]
4. Activity of the triazole antifungal r126638 as assessed by corneofungimetry.
Piérard-Franchimont C; Ausma J; Wouters L; Vroome V; Vandeplassche L; Borgers M; Cauwenbergh G; Piérard GE
Skin Pharmacol Physiol; 2006; 19(1):50-6. PubMed ID: 16247249
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
6. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
Xu W; Zhao JY; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds.
Guillot J; Bensignor E; Jankowski F; Seewald W; Chermette R; Steffan J
Vet Dermatol; 2003 Jun; 14(3):153-7. PubMed ID: 12791049
[TBL] [Abstract][Full Text] [Related]
9. Povidone-iodine wash solutions in the prevention of superficial fungal infections; predictive evaluation using the corneofungimetry bioassay.
Piérard GE; Piérard-Franchimont C; Arrese JE
Eur J Clin Pharmacol; 1997; 53(2):101-4. PubMed ID: 9403279
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study.
Rosales MS; Marsella R; Kunkle G; Harris BL; Nicklin CF; Lopez J
Vet Dermatol; 2005 Jun; 16(3):171-6. PubMed ID: 15960630
[TBL] [Abstract][Full Text] [Related]
12. The treatment of dermatophytosis: safety considerations.
Smith EB
J Am Acad Dermatol; 2000 Nov; 43(5 Suppl):S113-9. PubMed ID: 11044286
[No Abstract] [Full Text] [Related]
13. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.
Kienzler JL; Queille-Roussel C; Mugglestone C; Ortonne JP; Larnier C
Curr Med Res Opin; 2007 Jun; 23(6):1293-302. PubMed ID: 17559730
[TBL] [Abstract][Full Text] [Related]
14. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.
Faergemann J; Zehender H; Denouël J; Millerioux L
Acta Derm Venereol; 1993 Aug; 73(4):305-9. PubMed ID: 7904107
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum.
Pershing LK; Corlett J; Jorgensen C
Antimicrob Agents Chemother; 1994 Jan; 38(1):90-5. PubMed ID: 8141586
[TBL] [Abstract][Full Text] [Related]
16. New oral treatments for dermatophytosis.
Hay RJ
Ann N Y Acad Sci; 1988; 544():580-5. PubMed ID: 2850758
[No Abstract] [Full Text] [Related]
17. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
18. Activity of terbinafine in experimental fungal infections of laboratory animals.
Petranyi G; Meingassner JG; Mieth H
Antimicrob Agents Chemother; 1987 Oct; 31(10):1558-61. PubMed ID: 3435103
[TBL] [Abstract][Full Text] [Related]
19. Update on antifungal therapy with terbinafine.
Gianni C
G Ital Dermatol Venereol; 2010 Jun; 145(3):415-24. PubMed ID: 20461049
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of fluconazole and ketoconazole in human stratum corneum and oral mucosa.
Piérard GE; Rurangirwa A; Piérard-Franchimont C
Clin Exp Dermatol; 1991 May; 16(3):168-71. PubMed ID: 1934566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
